The impact of the muscle mass-to-fat ratio on the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer

被引:0
|
作者
Xu, Long-Jie [1 ]
Zhang, Sheng-Qiang [1 ]
Cao, Chun [1 ]
机构
[1] Soochow Univ, Dept Gen Surg, Affiliated Hosp 2, Suzhou 215004, Peoples R China
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2025年 / 41卷 / 02期
基金
中国国家自然科学基金;
关键词
complications; muscle mass-to-fat ratio; overall survival; pancreatic cancer; pancreaticoduodenectomy; SKELETAL-MUSCLE; INFLAMMATION; SARCOPENIA; FISTULA; RISK;
D O I
10.1002/kjm2.12928
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To evaluate the relationship between the muscle mass-to-fat ratio (MMFR) at the third lumbar spine (L3) and overall survival (OS) as well as related complications after pancreaticoduodenectomy (PD) for pancreatic cancer. Patients who underwent PD for pancreatic cancer between March 2017 and May 2023 at the Second Affiliated Hospital of Soochow University were included. Muscle mass and fat content at the L3 were measured by computed tomography. The specific formula that was used to calculate the MMFR was total abdominal muscle area/(subcutaneous adipose tissue area + visceral adipose tissue area), and the optimal cutoff values of the MMFR based on receiver operating characteristic curves were 0.688 for males and 0.382 for females. Patient characteristics were collected, and multivariate analyses were used to evaluate the impact of the MMFR on prognosis. Kaplan-Meier survival curves and log-rank tests were used to compare OS between the high-MMFR and low-MMFR groups. On the basis of the optimal cutoff values, 191 patients were divided into two groups, with 91 patients in the low-MMFR group and 100 patients in the high-MMFR group. The incidence of POPF was significantly greater in the low-MMFR group than in the high-MMFR group. According to multivariate analysis, the MMFR was an independent factor associated with POPF and OS. Patients with low MMFRs had significantly shorter OS and a greater POPF incidence than did those with high MMFRs. The MMFR is an independent predictor of POPF and affects the OS of patients undergoing PD for pancreatic cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
    Nakajima, Hiroki
    Yamaguchi, Junpei
    Takami, Hideki
    Hayashi, Masamichi
    Kodera, Yasuhiro
    Nishida, Yoshihiro
    Watanabe, Nobuyuki
    Onoe, Shunsuke
    Mizuno, Takashi
    Yokoyama, Yukihiro
    Ebata, Tomoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (05) : 688 - 697
  • [2] Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
    Hiroki Nakajima
    Junpei Yamaguchi
    Hideki Takami
    Masamichi Hayashi
    Yasuhiro Kodera
    Yoshihiro Nishida
    Nobuyuki Watanabe
    Shunsuke Onoe
    Takashi Mizuno
    Yukihiro Yokoyama
    Tomoki Ebata
    International Journal of Clinical Oncology, 2023, 28 : 688 - 697
  • [3] Effects of accelerated rehabilitation surgery on the clinical prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer
    Chu, Peng
    Wang, Zhaohui
    Zhi, Liang
    MINERVA GASTROENTEROLOGY, 2022, 68 (02): : 253 - 255
  • [4] Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy
    Yamanaka, T. A. K. A. H. I. R. O.
    Harimoto, N. O. R. I. F. U. M. I.
    Muranushi, R. Y. O.
    Hoshino, K. O. U. K., I
    Hagiwara, K. E., I
    Ishii, N. O. R. I. H. I. R. O.
    Tsukagoshi, M. A. R. I. K. O.
    Watanabe, A. K. I. R. A.
    Araki, K. E. N. I. C. H. I. R. O.
    Shirabe, K. E. N.
    ANTICANCER RESEARCH, 2022, 42 (12) : 5971 - 5976
  • [5] The impact of preoperative renal insufficiency on the outcomes of patients with pancreatic cancer undergoing pancreaticoduodenectomy
    Tamura, Shunsuke
    Kanemoto, Hideyuki
    Fujita, Akitsugu
    Tokuda, Satoshi
    Takagi, Akihiko
    Nakatani, Eiji
    Taku, Keisei
    Oba, Noriyuki
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [6] The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer
    Shirai, Yoshihiro
    Hamura, Ryoga
    Tanji, Yoshiaki
    Taniai, Tomohiko
    Yanagaki, Mitsuru
    Haruki, Koichiro
    Furukawa, Kenei
    Onda, Shinji
    Sakamoto, Taro
    Gocho, Takeshi
    Ikegami, Toru
    SURGERY TODAY, 2024, 54 (03) : 247 - 257
  • [7] The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer
    Yoshihiro Shirai
    Ryoga Hamura
    Yoshiaki Tanji
    Tomohiko Taniai
    Mitsuru Yanagaki
    Koichiro Haruki
    Kenei Furukawa
    Shinji Onda
    Taro Sakamoto
    Takeshi Gocho
    Toru Ikegami
    Surgery Today, 2024, 54 : 247 - 257
  • [8] The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer
    Zhao, Jing
    Bi, Yue
    SURGERY TODAY, 2024, 54 (12) : 1520 - 1520
  • [9] Impact of Weight Loss on Surgical Outcomes in Resectable Pancreatic Cancer Patients Undergoing Pancreaticoduodenectomy (PD)
    Emerenziani, Sara
    Valeri, Sergio
    Muscaritoli, Maurizio
    Guarino, Michele Pier Luca
    Molfino, Alessio
    Cocca, Silvia
    Rescio, Maria Paola
    Asensio, Laura Maria Trillo
    Lucia, Simone
    Cicala, Michele
    Coppola, Roberto
    GASTROENTEROLOGY, 2016, 150 (04) : S319 - S319
  • [10] Impact of neoadjuvant chemotherapy on postoperative pancreatic fistula in patients undergoing pancreaticoduodenectomy
    Tanno, Lulu
    Davies, Charlotte
    Stevens, Claire
    Fristedt, Richard
    Arshad, Ali
    Hamady, Zaed
    Armstrong, Thomas
    Primrose, John
    Karavias, Dimitrios
    Takhar, Arjun
    BRITISH JOURNAL OF SURGERY, 2021, 108